Jane Porretta
Overview
Explore the profile of Jane Porretta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Potter S, Gulbahce E, Porretta J, Lomo L, Duffy K, Winkler N, et al.
Am J Dermatopathol
. 2024 Dec;
47(3):220-223.
PMID: 39665459
In this unusual case, a 73-year-old woman presented with bloody discharge from her right breast and skin thickening was observed on subsequent imaging. Clinically, the findings raised concern for Paget...
2.
Vaklavas C, Matsen C, Chu Z, Boucher K, Scherer S, Pathi S, et al.
JCO Precis Oncol
. 2024 Jul;
8:e2300724.
PMID: 39074345
Purpose: Assessing risk of recurrence for nonmetastatic triple-negative breast cancer (TNBC) is a key determinant of therapeutic strategy. The best predictor of recurrence risk is failure to achieve a pathologic...
3.
Serpico V, Mone M, Zhang C, Presson A, Killian H, Agarwal J, et al.
J Plast Reconstr Aesthet Surg
. 2021 Nov;
75(2):528-535.
PMID: 34824026
Background: Mastectomy with immediate reconstruction is a high-risk cohort for postoperative nausea and vomiting (PONV). Known risk factors for PONV include female gender, prior PONV history, nonsmoker, age < 50,...
4.
Serpico V, Mone M, Zhang C, Presson A, Matsen C, Junkins S, et al.
Breast J
. 2020 Mar;
26(5):966-970.
PMID: 32128912
Standardized nonopioid preoperative protocol effects perioperative opioids. Combined use of acetaminophen, pregabalin, celecoxib, and transdermal scopolamine (APCS), in mastectomy with immediate subpectoral reconstruction procedures. Retrospective (2014-2017) cohort study (n = ...
5.
Cohen A, Factor R, Mooney K, Salama M, Wade M, Serpico V, et al.
Breast
. 2016 Dec;
31:219-223.
PMID: 27915204
Objectives: A decrease in Ki67 during neoadjuvant therapy predicts response to tamoxifen. Previous trials have shown a decreased Ki67 in breast tumors with as little as two or more weeks...